Articles
Bionomics initiates phase Ib trial of anxiety drug
Bionomics (ASX:BNO) has commenced a phase Ib trial of BNC210, its anxiety and depression drug candidate, and is laying the groundwork for a phase IIa trial due to begin this quarter. [ + ]
Detecting dengue antibodies in saliva
The Institute of Bioengineering and Nanotechnology (IBN) at A*STAR has developed a paper-based disposable device that will allow dengue-specific antibodies to be detected easily from saliva within 20 min. [ + ]
Novogen on track to regaining Nasdaq compliance
Novogen (ASX:NRT) has completed placements to ensure it regains compliance with Nasdaq listing rules, while CEO Dr Graham Kelly prepares to present at two investor conferences over the next two weeks. [ + ]
GTG secures new BREVAGen contracts
Shares in Genetic Technologies (ASX:GTG) more than doubled after the company revealed that up to six new breast centres will stock its BREVAGen breast cancer risk test in Q1, with more contracts on the way. [ + ]
A powerful web resource for viewing proteins
Scientists have announced the release of Aquaria - a publicly available web resource that streamlines and simplifies the process of gleaning insight from 3D protein structures. [ + ]
Alchemia to pursue deals for core assets
Alchemia (ASX:ACL) plans to explore sales or partnership opportunities for its core assets fondaparinux, its HyACT oncology platform and its VAST drug discovery platform. [ + ]
Genetically modified E. coli dependent on synthetic nutrients
While genetically modified organisms (GMOs) have imparted many benefits on society, they also have the potential to upset natural ecosystems if they were to escape. Physical containment of GMOs is not foolproof, so attention has since turned to biocontainment. [ + ]
Sirtex gets government grant for brain cancer R&D
Sirtex Medical (ASX:SRX) has secured a $50,000 Research Connections grant for a project to adapt its SIR-Spheres technology to treat brain cancer and other diseases. [ + ]
Unveiling the avian tree of life
A team of scientists has sequenced the genomes of 48 bird species, creating the most detailed tree of life for birds to date. [ + ]
Prima BioMed in for seven-figure payday
GSK has commenced a phase I trial of antibody technology licensed from Prima BioMed's newly acquired Immutep subsidiary, triggering a seven-figure milestone payment. [ + ]
Peter Lewis wins Order of Australia honour
Australian biotech veteran Peter Lewis has been named a Member of the Order of Australia for his contribution to international trade, biotech and ICT. [ + ]
Bacterial banter: new method of chemical communication discovered
A team of German scientists, led by Dr Helge B Bode from Goethe University and Dr Ralf Heermann from Ludwig Maximilian University, has succeeded in decoding a previously unknown yet widely distributed chemical type of bacterial communication. [ + ]
Bacterial banter: new method of chemical communication discovered
A team of German scientists, led by Dr Helge B Bode from Goethe University and Dr Ralf Heermann from Ludwig Maximilian University, has succeeded in decoding a previously unknown yet widely distributed chemical type of bacterial communication. [ + ]
Cosmic radio waves caught in real time
Swinburne University of Technology PhD student Emily Petroff has become the first person to observe a 'fast radio burst' - a short, bright flash of radio waves from an unknown source - happening live. [ + ]
Cosmic radio waves caught in real time
Swinburne University of Technology PhD student Emily Petroff has become the first person to observe a 'fast radio burst' - a short, bright flash of radio waves from an unknown source - happening live. [ + ]